CoChat
Sign Up
Cited by 29

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Apolipoprotein A1 Forms 5/5 and 5/4 Antiparallel Dimers in Human High-density Lipoprotein

He, Yi, Song, Hyun D., Anantharamaiah, G.M., Palgunachari, M.N., Bornfeldt, Karin E., Segrest, Jere P., Heinecke, Jay W.·2019·Molecular & Cellular Proteomics
DOI 10.1074/mcp.ra118.000878
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1074/mcp.ra118.000878

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Show all 3 references

Research works printed but not linked: 54

  1. Glomset, 1968, The plasma lecithins:cholesterol acyltransferase reaction, J. Lipid Res, 9, 155, 10.1016/S0022-2275(20)43114-1 · DOI
  2. Glomset, 1964, Some Properties of a Cholesterol Esterifying Enzyme in Human Plasma, Biochim. Biophys. Acta, 89, 266
  3. Wilson, 1988, High density lipoprotein cholesterol and mortality. The Framingham Heart Study, Arteriosclerosis, 8, 737, 10.1161/01.ATV.8.6.737 · DOI
  4. Mahdy Ali, 2012, Cardiovascular disease risk reduction by raising HDL cholesterol–current therapies and future opportunities, Br. J. Pharmacol, 167, 1177, 10.1111/j.1476-5381.2012.02081.x · DOI
  5. Davidson, 2009, Proteomic analysis of defined HDL subpopulations reveals particle-specific protein clusters: relevance to antioxidative function, Arterioscler. Thromb. Vasc. Biol, 29, 870, 10.1161/ATVBAHA.109.186031 · DOI · Paper page
  6. Gordon, 2015, Rosuvastatin alters the proteome of high density lipoproteins: generation of alpha-1-antitrypsin enriched particles with anti-inflammatory properties, Mol. Cell. Proteomics, 14, 3247, 10.1074/mcp.M115.054031 · DOI
  7. Oram, 2005, ATP-binding cassette transporter A1: a cell cholesterol exporter that protects against cardiovascular disease, Physiolog. Rev, 85, 1343, 10.1152/physrev.00005.2005 · DOI
  8. Shih, 2009, Maturation of high-density lipoproteins, J. R. Soc. Interface, 6, 863, 10.1098/rsif.2009.0173 · DOI
  9. Soutar, 1975, Effect of the human plasma apolipoproteins and phosphatidylcholine acyl donor on the activity of lecithin: cholesterol acyltransferase, Biochemistry, 14, 3057, 10.1021/bi00685a003 · DOI
  10. Hoekstra, 2016, Functionality of high-density lipoprotein as antiatherosclerotic therapeutic target, Arterioscler. Thromb. Vasc. Biol, 36, e87, 10.1161/ATVBAHA.116.308262 · DOI
  11. Karathanasis, 2017, The changing face of HDL and the best way to measure it, Clin. Chem, 63, 196, 10.1373/clinchem.2016.257725 · DOI
  12. Gao, 2009, Differential stability of high-density lipoprotein subclasses: effects of particle size and protein composition, J. Mol. Biol, 387, 628, 10.1016/j.jmb.2009.02.036 · DOI
  13. Movva, 2008, Laboratory assessment of HDL heterogeneity and function, Clin. Chem, 54, 788, 10.1373/clinchem.2007.101923 · DOI
  14. Rosenson, 2011, HDL measures, particle heterogeneity, proposed nomenclature, and relation to atherosclerotic cardiovascular events, Clin. Chem, 57, 392, 10.1373/clinchem.2010.155333 · DOI
  15. Borhani, 1997, Crystal structure of truncated human apolipoprotein A-I suggests a lipid-bound conformation, Proc. Natl. Acad. Sci. U.S.A, 94, 12291, 10.1073/pnas.94.23.12291 · DOI
  16. Segrest, 1999, A detailed molecular belt model for apolipoprotein A-I in discoidal high density lipoprotein, J. Biol. Chem, 274, 31755, 10.1074/jbc.274.45.31755 · DOI
  17. Brouillette, 2001, Structural models of human apolipoprotein A-I: a critical analysis and review, Biochim. Biophys. Acta, 1531, 4, 10.1016/S1388-1981(01)00081-6 · DOI
  18. Li, 2002, ApoA-I structure on discs and spheres. Variable helix registry and conformational states, J. Biol. Chem, 277, 39093, 10.1074/jbc.M206770200 · DOI
  19. Carlson, 1997, Imaging and manipulation of high-density lipoproteins, Biophys. J, 73, 1184, 10.1016/S0006-3495(97)78150-5 · DOI
  20. Nath, 2007, Applications of phospholipid bilayer nanodiscs in the study of membranes and membrane proteins, Biochemistry, 46, 2059, 10.1021/bi602371n · DOI
  21. Bhat, 2007, Conformational adaptation of apolipoprotein A-I to discretely sized phospholipid complexes, Biochemistry, 46, 7811, 10.1021/bi700384t · DOI
  22. Shih, 2008, Molecular models need to be tested: the case of a solar flares discoidal HDL model, Biophys. J, 94, L87, 10.1529/biophysj.108.131581 · DOI
  23. Marty, 2012, Native mass spectrometry characterization of intact nanodisc lipoprotein complexes, Anal. Chem, 84, 8957, 10.1021/ac302663f · DOI
  24. Phillips, 2014, Molecular mechanisms of cellular cholesterol efflux, J. Biol. Chem, 289, 24020, 10.1074/jbc.R114.583658 · DOI
  25. Mei, 2011, Crystal structure of C-terminal truncated apolipoprotein A-I reveals the assembly of high density lipoprotein (HDL) by dimerization, J. Biol. Chem, 286, 38570, 10.1074/jbc.M111.260422 · DOI
  26. Li, 2012, Rotational and hinge dynamics of discoidal high density lipoproteins probed by interchain disulfide bond formation, Biochim. Biophys. Acta, 1821, 481, 10.1016/j.bbalip.2011.10.013 · DOI
  27. Liu, 2015, Interrogating the architecture of protein assemblies and protein interaction networks by cross-linking mass spectrometry, Curr. Opin. Struct. Biol, 35, 100, 10.1016/j.sbi.2015.10.006 · DOI
  28. Leitner, 2016, Crosslinking and mass spectrometry: an integrated technology to understand the structure and function of molecular machines, Trends Biochem. Sci, 41, 20, 10.1016/j.tibs.2015.10.008 · DOI
  29. Hage, 2017, The first zero-length mass spectrometry-cleavable cross-linker for protein structure analysis, Angew Chem. Int. Ed. Engl, 56, 14551, 10.1002/anie.201708273 · DOI
  30. Ryan, 2003, Optimized bacterial expression of human apolipoprotein A-I, Protein Expr. Purif, 27, 98, 10.1016/S1046-5928(02)00568-5 · DOI
  31. Cavigiolio, 2008, The interplay between size, morphology, stability, and functionality of high-density lipoprotein subclasses†, Biochemistry, 47, 4770, 10.1021/bi7023354 · DOI
  32. Ronsein, 2016, Targeted proteomics identifies paraoxonase/arylesterase 1 (PON1) and apolipoprotein Cs as potential risk factors for hypoalphalipoproteinemia in diabetic subjects treated with fenofibrate and rosiglitazone, Mol. Cell. Proteomics, 15, 1083, 10.1074/mcp.M115.054528 · DOI
  33. Hutchins, 2014, Quantification of HDL particle concentration by calibrated ion mobility analysis, Clin. Chem, 60, 1393, 10.1373/clinchem.2014.228114 · DOI
  34. Rinner, 2008, Identification of cross-linked peptides from large sequence databases, Nat. Methods, 5, 315, 10.1038/nmeth.1192 · DOI
  35. Walzthoeni, 2012, False discovery rate estimation for cross-linked peptides identified by mass spectrometry, Nat. Methods, 9, 901, 10.1038/nmeth.2103 · DOI
  36. Gordon, 2013, Multi-dimensional co-separation analysis reveals protein-protein interactions defining plasma lipoprotein subspecies, Mol. Cell. Proteomics, 12, 3123, 10.1074/mcp.M113.028134 · DOI
  37. Shah, 2013, Proteomic diversity of high density lipoproteins: our emerging understanding of its importance in lipid transport and beyond, J. Lipid Res, 54, 2575, 10.1194/jlr.R035725 · DOI
  38. Hoopmann, 2015, Kojak: efficient analysis of chemically cross-linked protein complexes, J. Proteome Res, 14, 2190, 10.1021/pr501321h · DOI
  39. Lima, 2015, SIM-XL: A powerful and user-friendly tool for peptide cross-linking analysis, J. Proteomics, 129, 51, 10.1016/j.jprot.2015.01.013 · DOI
  40. Phillips, 2005, Scalable molecular dynamics with NAMD, J. Comput. Chem, 26, 1781, 10.1002/jcc.20289 · DOI · Paper page
  41. Best, 2012, Optimization of the additive CHARMM all-atom protein force field targeting improved sampling of the backbone phi, psi and side-chain chi(1) and chi(2) dihedral angles, J. Chem. Theory Comput, 8, 3257, 10.1021/ct300400x · DOI
  42. Feller, 1995, Constant pressure molecular dynamics simulation: The Langevin piston method, J. Chem. Phys, 103, 4613, 10.1063/1.470648 · DOI
  43. Ryckaert, 1977, Numerical integration of the cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes, J. Computational Phys, 23, 327, 10.1016/0021-9991(77)90098-5 · DOI
  44. Miyamoto, 1992, Settle: An analytical version of the SHAKE and RATTLE algorithm for rigid water models, J. Computational Chem, 13, 952, 10.1002/jcc.540130805 · DOI
  45. Darden, 1993, Particle mesh Ewald: An N·log(N) method for Ewald sums in large systems, J. Chem. Phys, 98, 10089, 10.1063/1.464397 · DOI
  46. Hermanson, 1996, Bioconjugate techniques, San Diego, Academic Press
  47. Pourmousa, 2018, Tertiary structure of apolipoprotein A-I in nascent high-density lipoproteins, Proc. Natl. Acad. Sci. USA, 10.1073/pnas.1721181115 · DOI
  48. Segrest, 2014, An experimentally robust model of monomeric apolipoprotein A-I created from a chimera of two X-ray structures and molecular dynamics simulations, Biochemistry, 53, 7625, 10.1021/bi501111j · DOI
  49. Lima, 2018, Characterization of homodimer interfaces with cross-linking mass spectrometry and isotopically labeled proteins, Nat. Protoc, 13, 431, 10.1038/nprot.2017.113 · DOI
  50. Silva, 2005, A mass spectrometric determination of the conformation of dimeric apolipoprotein A-I in discoidal high density lipoproteins, Biochemistry, 44, 8600, 10.1021/bi050421z · DOI
  51. Gu, 2010, Structures of discoidal high density lipoproteins: a combined computational-experimental approach, J. Biol. Chem, 285, 4652, 10.1074/jbc.M109.069914 · DOI
  52. Bashtovyy, 2011, Sequence conservation of apolipoprotein A-I affords novel insights into HDL structure-function, J. Lipid Res, 52, 435, 10.1194/jlr.R012658 · DOI
  53. Brown, 2006, Breaking symmetry in protein dimers: designs and functions, Protein Sci, 15, 1, 10.1110/ps.051658406 · DOI
  54. Goodsell, 2000, Structural symmetry and protein function, Annu. Rev. Biophys. Biomol. Struct, 29, 105, 10.1146/annurev.biophys.29.1.105 · DOI · Paper page

Cited by

Sorted by citations

See all 29

Metadata

Authors
He, Y., Song, H. D., Anantharamaiah, G. M., Palgunachari, M. N., Bornfeldt, K. E., Segrest, J. P., & Heinecke, J. W.
Venue
Molecular & Cellular Proteomics
Publisher
Elsevier BV
Published
2019-05
Volume
18
Issue
5
Pages
854a-864
ISSN
1535-9476
DOI
10.1074/mcp.ra118.000878
Cited by
29
References
3
Language
en
Licence
Funders
  • HHS | National Institutes of Health (P01HL092969, DP3DK108209, P01HL128203)
  • American Heart Association (15POST22700033)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review